Primary treatment of acromegaly with octreotide LAR: a long-term (up to nine years) prospective study of its efficacy in the control of disease activity and tumor shrinkage - Cozzi, R; Montini, M; Attanasio, R (J Clin Endocrinol Metab, 2006)
et al.